SCHEMBL21362566

SCHEMBL21362566

COCc1ccc(C)cc1Br

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 8/20 0.41
ALDH1A1 P00352 4/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
MAPT P10636 6/20 0.40
TDP1 Q9NUW8 4/20 0.40
HPGD P15428 4/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CYP1A2 P05177 2/20 0.39
CYP2C19 P33261 2/20 0.39
CYP2D6 P10635 1/20 0.39
LMNA P02545 1/20 0.38
MAPK1 P28482 1/20 0.38
KDM4E B2RXH2 5/20 0.38
USP2 O75604 1/20 0.37
HSP90AA1 P07900 1/20 0.36
CYP2C9 P11712 1/20 0.36
ABL1 P00519 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13178886 0.83 FFAR4 (0.43) L3MBTL1ALDH1A1MEN1KMT2AMAPT
SCHEMBL4799391 0.81 PYCR1 (0.43) L3MBTL1ALDH1A1MEN1KMT2AMAPT
SCHEMBL8256542 0.80 KDM4E (0.41) ALDH1A1MEN1KMT2AMAPTTDP1
SCHEMBL6603605 0.79 APLNR (0.44) CYP1A2
SCHEMBL755548 0.79 PTPN1 (0.39) L3MBTL1ALDH1A1MEN1KMT2AMAPT
SCHEMBL1145658 0.78 KDM4E (0.51) L3MBTL1ALDH1A1MEN1KMT2AMAPT
SCHEMBL10817318 0.78 AMY1A (0.42) L3MBTL1ALDH1A1MEN1KMT2AMAPT
SCHEMBL19859281 0.78 IDO1 (0.41) L3MBTL1ALDH1A1MEN1KMT2AMAPT
SCHEMBL13327165 0.77 ALDH1A1 (0.41) L3MBTL1ALDH1A1MEN1KMT2AMAPT
SCHEMBL18570745 0.77 KDM4E (0.40) L3MBTL1ALDH1A1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed